Literature DB >> 27917573

Role of adrenocorticotropic hormone in essential hypertension and primary aldosteronism.

Decio Armanini1, Alessandra Andrisani2, Guido Ambrosini2, Luciana Bordin3, Chiara Sabbadin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27917573      PMCID： PMC8031167          DOI： 10.1111/jch.12951

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  19 in total

Review 1.  Corticosteroid receptors in lymphocytes: a possible marker of brain involution?

Authors:  D Armanini
Journal:  J Steroid Biochem Mol Biol       Date:  1994-06       Impact factor: 4.292

2.  Psychological assessment of primary aldosteronism: a controlled study.

Authors:  Nicoletta Sonino; Elena Tomba; Maria Luisa Genesia; Chiara Bertello; Paolo Mulatero; Franco Veglio; Giovanni A Fava; Francesco Fallo
Journal:  J Clin Endocrinol Metab       Date:  2011-03-09       Impact factor: 5.958

3.  Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.

Authors:  D C Kem; M H Weinberger; J R Higgins; N J Kramer; C Gomez-Sanchez; O B Holland
Journal:  J Clin Endocrinol Metab       Date:  1978-04       Impact factor: 5.958

4.  Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects.

Authors:  E M Freel; M Ingram; A M Wallace; A White; R Fraser; E Davies; J M C Connell
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

Review 5.  Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.

Authors:  Bertram Pitt
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

Review 6.  Syndromes that Mimic an Excess of Mineralocorticoids.

Authors:  Chiara Sabbadin; Decio Armanini
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-06-01

7.  Some Considerations About Primary Aldosteronism and Its Follow-Up.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

8.  Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism.

Authors:  Takuhiro Sonoyama; Masakatsu Sone; Naohisa Tamura; Kyoko Honda; Daisuke Taura; Katsutoshi Kojima; Yorihide Fukuda; Naotetsu Kanamoto; Masako Miura; Akihiro Yasoda; Hiroshi Arai; Hiroshi Itoh; Kazuwa Nakao
Journal:  Endocr Connect       Date:  2014-12       Impact factor: 3.335

9.  Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Authors:  Hiroki Kobayashi; Akira Haketa; Ueno Takahiro; Hiromasa Otsuka; Sho Tanaka; Yoshinari Hatanaka; Yukihiro Ikeda; Masanori Abe; Noboru Fukuda; Masayoshi Soma
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

10.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Authors:  Ute I Scholl; Gerald Goh; Gabriel Stölting; Regina Campos de Oliveira; Murim Choi; John D Overton; Annabelle L Fonseca; Reju Korah; Lee F Starker; John W Kunstman; Manju L Prasad; Erum A Hartung; Nelly Mauras; Matthew R Benson; Tammy Brady; Jay R Shapiro; Erin Loring; Carol Nelson-Williams; Steven K Libutti; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Peyman Björklund; Tobias Carling; Christoph Fahlke; Patricia Hidalgo; Richard P Lifton
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330
View more
  1 in total

1.  Relationship between water and salt intake, osmolality, vasopressin, and aldosterone in the regulation of blood pressure.

Authors:  Decio Armanini; Luciana Bordin; Gabriella Dona'; Alessandra Andrisani; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-19       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.